Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency is an inborn error of purine metabolism. Mutant HPRT gene sequences from patients deficient in enzyme activity have previously been characterized by cDNA cloning or amino acid sequencing techniques. The presence of HPRTspecific mRNA in nearly all deficient subjects, as well as the small size of the HPRT mRNA (1,400 bp), make the polymerase chain reaction (PCR) an alternative for the identification of mutations at this locus. In this report we use the PCR to identify previously undetermined mutations in HPRT mRNA from B lymphoblasts derived from 10 deficient individuals. Six of these variants contain single point mutations, three contain deletions, and one contains a single nucleotide insertion. Several of these mutations map near previously identified HPRT variants, and are located in evolutionarily conserved regions of the molecule.
Introduction
Hypoxanthine-guanine phosphoribosyltransferase (HPRT)1 deficiency is a disorder of purine metabolism responsible for two distinct clinical syndromes. Complete deficiency ofHPRT 1 . Abbreviations used in this paper: dNTP, deoxynucleoside triphosphate; HPRT, hypoxanthine-guanine phosphoribosyltransferase; PCR, polymerase chain reaction; PRPP, 5-phosphoribosyl-l-pyrophosphate. (4, 5) . The original hypothesis proposed to explain these observations was that different, independent mutations occurred in the structural gene (6) . Subsequent molecular studies confirmed this observation (7, 8) . More recently, amino acid sequencing and cDNA cloning have been used to identify the molecular basis of HPRT deficiency in 11 subjects (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) .
Study ofthese naturally occurring mutants has revealed the structural and catalytic importance of certain regions of the molecule. However, the techniques used to identify these mutations are laborious, and have been dependent on sufficient residual levels of HPRT protein for amino acid sequence analysis or HPRT-specific mRNA for cDNA cloning.
In this report, we have used the polymerase chain reaction (PCR) to amplify HPRT-specific sequences from total RNA isolated from B lymphoblasts derived from 10 patients (20) . Three of these subjects have partial deficiency and seven have Lesch-Nyhan syndrome. Direct sequencing of the amplified products allowed rapid identification of mutant gene sequences. This technique is applicable to the identification of mutations and carrier status for any inborn error of metabolism for which normal DNA sequence information is available. From these data, important structure-function relationships can be inferred.
Methods
Cell lines. The methods used to establish and maintain B lymphoblastoid cell lines have been described (21 RNA isolation and in vitro amplification. RNA was isolated from the above cell lines using guanidium isothiocyanate (22 Sequencing. Sequencing of the amplified HPRT transcripts was done directly without cloning using dideoxynucleotide chain termination (24) . All of the coding sequence of both strands was sequenced using eight HPRT-specific oligodeoxynucleotides that hybridize to HPRT coding sequence internal to the PCR primers. The primers were phosphorylated with [y-32P]dATP (6,000 Ci/mmol) and T4 polynucleotide kinase and used in eight separate sets of sequencing reactions (13, 25). The regions to which these primers anneal, and the extent of overlap of the sequence generated, are depicted in Fig. 2 . Direct sequencing was done using a modification ofthe procedures described by Engelke et al. (26) . 2 gl amplified DNA was combined with 4 Ml of ddNTP mixture (600 Am each dNTP and 40 Mm of the appropriate dideoxynucleotide), 4 Ml of lox buffer (IX buffer is 20 mM Hepes, pH 7.5, 50 mM NaCl, and 10 mM MgCl2), and 100,000 cpm of one ofthe 32P-labeled HPRT-specific primers. The samples, in a total reaction vol of 40 Al, were denatured for 3 min at 95°C, then placed at 42°C for 5 min to allow the primer to anneal. This was followed by the addition of 1 U of Sequenase (U.S. Biochemical Corp., Cleveland, OH) and a 5-min polymerization step at 42°C. The denature/anneal/polymerize cycle was repeated twice. A solution of proteinase K (1 mg/ml), SDS (2%), and EDTA (100 mM, pH 8.0) was added, and the reaction mixture was incubated at 50°C for 30 min. The samples were precipitated on dry ice after the addition of EDTA, NaCl, glycogen (final concentrations 7 mM, 100 mM, and 0.02 mg/ml, respectively), and 2 vol ofethanol, and resuspended in 8 Ml ofdideoxy sequencing dye (98% formamide, 10 mM EDTA, and 0.1% xylene cyanol FF and bromophenol blue). An aliquot ofeach reaction (4 Ml) was electrophoresed at constant wattage (60 W) for either 1.5 or 3 h through 4% polyacrylamide gels containing 8 M urea. The gels were fixed in 5% methanol/ 5% acetic acid for 10 min, transferred to 3MM paper (Whatman Laboratory Products Inc., Clifton, NJ), dried under vacuum at 80°C, and autoradiographed.
Enzyme analyses. HPRT enzyme activity was measured in membrane-free lysates as previously described (27 (7) . This is consistent with the predicted glycine to glumatic acid substitution at amino acid 70. The predicted electrophoretic alteration in HPRTArlington was confirmed using an HPRT activity assay on native protein in polyacrylamide gels (see Methods). The hypoxanthine, PRPP, and MgCl2 were > 20, 75, and 7.2 times higher than the substrate concentrations used under normal assay conditions so that any kinetic incapacity would be overcome. As shown in Fig. 2 , HPRTArlington is a basic variant, consistant with the aspartic acid to valine substitution.
Discussion
In the past, the basis of HPRT deficiency states has been characterized through the use of amino acid sequencing (9) (10) (11) (12) , cDNA cloning (13-19), and in one recent case, by denaturing gradient gel electrophoresis followed by amplification of the region of interest by the PCR (30) . These methods are time consuming and labor intensive. More recently, the sequence of PCR-amplified transcripts from HPRTLondon and normal HPRT have been reported (17, 31) . In both cases sequences were determined by cloning into Ml 3 bacteriophage and sequencing. However the misincorporation rate ofTaq polymerase (2 X 10-4/nucleotide per cycle [20] ) necessitates sequencing many independent clones to authenticate mutations. In this report we use direct sequencing of PCR-amplified products to circumvent both ofthese problems in the identification of nine previously undescribed mutations.
The molecular basis of HPRT deficiency in 20 of 24 deficient subjects from our original survey population have now been defined. This includes two recently acquired variants, HPRTArlington and HPRTDeroit. Of the remaining four HPRT variants from this population, four have undetectable levels of HPRT mRNA on Northern blot analysis, but have no gross genetic rearrangements on Southern blots. The remaining variant is currently under study. Thus, the population of 20 variants2 consists of 13 point mutations (65%), 5 deletions (25%), 1 single nucleotide insertion (5%), and 1 duplication (5%).
Although the deletions in HPRTc(onnreiuij and HPRTE,,V,,"V and the insertion in HPRTchi0go predict grossly altered protein structures, single amino acid substitutions or small deletions may affect protein stability, kinetic capacity, or subunit interactions as well (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . To investigate whether those variants with point mutations or a single codon deletion may cause structural perturbations, we used the PEPTIDESTRUCTURE and PLOTSTRUCTURE programs ofthe Genetics Computer Group to predict structural changes (29). As summarized in Table II of these variants is decreased substrate affinity demonstrated by large increases in the Km's for both PRPP and hypoxanthine (12, 18, 33) . Secondary structure analysis predicts changes in the hydrophilicity of the protein in the area surrounding these mutations. The kinetic parameters for HPRTNew Briton cannot be determined due to insufficient levels of protein (7) . Although changes in secondary structure parameters are altered in most HPRT variants, correlating changes in secondary structure to the loss of enzyme function are speculative. In the absence of known three-dimensional structures for the native and mutant proteins predictive programs of this type are one way to assess the possible impact of amino acid substitutions. Estimates of accuracy using these predictive techniques range from 50 to 70% (34, 35) .
In summary, PCR is a rapid means for determining mutations in HPRT, allowing the identification of nine additional variants. Although mutations in HPRT are scattered throughout the molecule, clusters of mutations are now apparent. The location of these regions, in concert with secondary structure predictions, refines our understanding of structural features in HPRT that may be necessary for proper enzymatic function and stability. 
